A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

Clinical trial NCT03855995 · COMPLETED

Trial details

NCT number: NCT03855995
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Malaria Malaria Vaccines

Start date: 2019-03-21
Primary completion: 2025-08-07
Enrollment: 77953

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.